{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:19:47Z","timestamp":1791908387886,"version":"4.3.4"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T00:00:00Z","timestamp":1692144000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T00:00:00Z","timestamp":1692144000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Headache Pain"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>It is unknown whether new daily persistent headache (NDPH) is a single disorder or heterogenous group of disorders, and whether it is a unique disorder from chronic migraine and chronic tension-type headache. We describe a large group of patients with primary NDPH, compare its phenotype to transformed chronic daily headache (T-CDH), and use cluster analysis to reveal potential sub-phenotypes in the NDPH group.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We performed a case\u2013control study using prospectively collected clinical data in patients with primary NDPH and T-CDH (encompassing chronic migraine and chronic tension-type headache). We used logistic regression with propensity score matching to compare demographics, phenotype, comorbidities, and treatment responses between NDPH and T-CDH. We used K-means cluster analysis with Gower distance to identify sub-clusters in the NDPH group based on a combination of demographics, phenotype, and comorbidities.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We identified 366 patients with NDPH and 696 with T-CDH who met inclusion criteria. Patients with NDPH were less likely to be female (62.6% vs. 73.3%, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). Nausea, vomiting, photophobia, phonophobia, motion sensitivity, vertigo, and cranial autonomic symptoms were all significantly less frequent in NDPH than T-CDH (<jats:italic>p<\/jats:italic> value for all\u2009&lt;\u20090.001). Acute treatments appeared less effective in NDPH than T-CDH, and medication overuse was less common (16% vs. 42%, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). Response to most classes of oral preventive treatments was poor in both groups. The most effective treatment in NDPH was doselupin in 45.7% patients (95% CI 34.8\u201356.5%). Cluster analysis identified three subgroups of NDPH. Cluster 1 was older, had a high proportion of male patients, and less severe headaches. Cluster 2 was predominantly female, had severe headaches, and few associated symptoms. Cluster 3 was predominantly female with a high prevalence of migrainous symptoms and headache triggers.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Whilst there is overlap in the phenotype of NDPH and T-CDH, the differences in migrainous, cranial autonomic symptoms, and vulnerability to medication overuse suggest that they are not the same disorder. NDPH may be fractionated into three sub-phenotypes, which require further investigation.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s10194-023-01639-5","type":"journal-article","created":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T10:02:33Z","timestamp":1692180153000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Phenotype of new daily persistent headache: subtypes and comparison to transformed chronic daily headache"],"prefix":"10.1186","volume":"24","author":[{"given":"Sanjay","family":"Cheema","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anker","family":"Stubberud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khadija","family":"Rantell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parashkev","family":"Nachev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erling","family":"Tronvik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manjit","family":"Matharu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,16]]},"reference":[{"issue":"1","key":"1639_CR1","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s10194-022-01402-2","volume":"23","author":"LJ Stovner","year":"2022","unstructured":"Stovner LJ, Hagen K, Linde M, Steiner TJ (2022) The global prevalence of headache: an update, with analysis of the influences of methodological factors on prevalence estimates. J Headache Pain 23(1):34. https:\/\/doi.org\/10.1186\/s10194-022-01402-2","journal-title":"J Headache Pain"},{"issue":"3","key":"1639_CR2","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1046\/j.1526-4610.1999.3903190.x","volume":"39","author":"J Castillo","year":"1999","unstructured":"Castillo J, Munoz P, Guitera V, Pascual J (1999) Kaplan Award 1998. Epidemiology of chronic daily headache in the general population. Headache 39(3):190\u20136. https:\/\/doi.org\/10.1046\/j.1526-4610.1999.3903190.x","journal-title":"Headache"},{"key":"1639_CR3","doi-asserted-by":"publisher","unstructured":"Headache Classification Committee of the International Headache Society (2018). The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 38(1):1\u2013211. https:\/\/doi.org\/10.1177\/0333102417738202","DOI":"10.1177\/0333102417738202"},{"issue":"5","key":"1639_CR4","doi-asserted-by":"publisher","first-page":"333102423116808","DOI":"10.1177\/03331024231168089","volume":"43","author":"S Cheema","year":"2023","unstructured":"Cheema S, Mehta D, Ray JC, Hutton EJ, Matharu MS (2023) New daily persistent headache: a systematic review and meta-analysis. Cephalalgia 43(5):3331024231168089. https:\/\/doi.org\/10.1177\/03331024231168089","journal-title":"Cephalalgia"},{"issue":"10","key":"1639_CR5","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1111\/head.14207","volume":"61","author":"RW Evans","year":"2021","unstructured":"Evans RW, Turner DP (2021) Clinical features of new daily persistent headache: a retrospective chart review of 328 cases. Headache 61(10):1529\u20131538. https:\/\/doi.org\/10.1111\/head.14207","journal-title":"Headache"},{"issue":"4\u20135","key":"1639_CR6","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1177\/03331024211044440","volume":"42","author":"R Lobo","year":"2022","unstructured":"Lobo R, Wang M, Lobo S, Bahra A (2022) Time to retire \u201cnew daily persistent headache\u201d: mode of onset of chronic migraine and tension-type headache. Cephalalgia 42(4\u20135):385\u2013395. https:\/\/doi.org\/10.1177\/03331024211044440","journal-title":"Cephalalgia"},{"issue":"1","key":"1639_CR7","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1046\/j.1468-2982.2002.00326.x","volume":"22","author":"D Li","year":"2002","unstructured":"Li D, Rozen TD (2002) The clinical characteristics of new daily persistent headache. Cephalalgia 22(1):66\u201369. https:\/\/doi.org\/10.1046\/j.1468-2982.2002.00326.x","journal-title":"Cephalalgia"},{"key":"1639_CR8","doi-asserted-by":"publisher","unstructured":"Goadsby PJ, Boes C (2002) New daily persistent headache. J Neurol Neurosurg Psychiatry. 72(2):ii6\u2013ii9. https:\/\/doi.org\/10.1136\/jnnp.72.suppl_2.ii6","DOI":"10.1136\/jnnp.72.suppl_2.ii6"},{"issue":"8","key":"1639_CR9","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1046\/j.1526-4610.2001.01152.x","volume":"41","author":"RW Evans","year":"2001","unstructured":"Evans RW, Rozen TD (2001) Etiology and treatment of new daily persistent headache. Headache 41(8):830\u2013832. https:\/\/doi.org\/10.1046\/j.1526-4610.2001.01152.x","journal-title":"Headache"},{"issue":"4","key":"1639_CR10","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1111\/j.1526-4610.2011.01872.x","volume":"51","author":"PJ Goadsby","year":"2011","unstructured":"Goadsby PJ (2011) New daily persistent headache: a syndrome, not a discrete disorder. Headache 51(4):650\u2013653. https:\/\/doi.org\/10.1111\/j.1526-4610.2011.01872.x","journal-title":"Headache"},{"issue":"2","key":"1639_CR11","doi-asserted-by":"publisher","first-page":"333102422114631","DOI":"10.1177\/03331024221146314","volume":"43","author":"KP Peng","year":"2023","unstructured":"Peng KP, Rozen TD (2023) Update in the understanding of new daily persistent headache. Cephalalgia 43(2):3331024221146314. https:\/\/doi.org\/10.1177\/03331024221146314","journal-title":"Cephalalgia"},{"key":"1639_CR12","doi-asserted-by":"publisher","first-page":"842306","DOI":"10.3389\/frai.2022.842306","volume":"5","author":"TJ Loftus","year":"2022","unstructured":"Loftus TJ, Shickel B, Balch JA, Tighe PJ, Abbott KL, Fazzone B et al (2022) Phenotype clustering in health care: A narrative review for clinicians. Front Artif Intell. 5:842306. https:\/\/doi.org\/10.3389\/frai.2022.842306","journal-title":"Front Artif Intell."},{"issue":"8","key":"1639_CR13","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1023\/a:1026119331193","volume":"12","author":"M Kosinski","year":"2003","unstructured":"Kosinski M, Bayliss MS, Bjorner JB, Ware JE Jr, Garber WH, Batenhorst A et al (2003) A six-item short-form survey for measuring headache impact: the HIT-6. Qual Life Res 12(8):963\u2013974. https:\/\/doi.org\/10.1023\/a:1026119331193","journal-title":"Qual Life Res"},{"issue":"2","key":"1639_CR14","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1046\/j.1468-2982.1999.019002107.x","volume":"19","author":"WF Stewart","year":"1999","unstructured":"Stewart WF, Lipton RB, Kolodner K, Liberman J, Sawyer J (1999) Reliability of the migraine disability assessment score in a population-based sample of headache sufferers. Cephalalgia 19(2):107\u201314. https:\/\/doi.org\/10.1046\/j.1468-2982.1999.019002107.x. (Discussion 74)","journal-title":"Cephalalgia"},{"issue":"6","key":"1639_CR15","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","volume":"67","author":"AS Zigmond","year":"1983","unstructured":"Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67(6):361\u2013370. https:\/\/doi.org\/10.1111\/j.1600-0447.1983.tb09716.x","journal-title":"Acta Psychiatr Scand"},{"issue":"3","key":"1639_CR16","doi-asserted-by":"publisher","first-page":"fcac059","DOI":"10.1093\/braincomms\/fcac059","volume":"4","author":"A Stubberud","year":"2022","unstructured":"Stubberud A, Gray R, Tronvik E, Matharu M, Nachev P (2022) Machine prescription for chronic migraine. Brain Communications. 4(3):fcac059. https:\/\/doi.org\/10.1093\/braincomms\/fcac059","journal-title":"Brain Communications."},{"issue":"1","key":"1639_CR17","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/biomet\/70.1.41","volume":"70","author":"PR Rosenbaum","year":"1983","unstructured":"Rosenbaum PR, Rubin DB (1983) The central role of the propensity score in observational studies for causal effects. Biometrika 70(1):41\u201355","journal-title":"Biometrika"},{"key":"1639_CR18","doi-asserted-by":"publisher","DOI":"10.1002\/0471722146","volume-title":"Applied Logistic Regression","author":"DW Hosmer","year":"2000","unstructured":"Hosmer DW, Lemeshow S (2000) Applied Logistic Regression, 2nd edn. Wiley, New Jersey","edition":"2"},{"key":"1639_CR19","volume-title":"Cluster analysis for applications","author":"MR Anderberg","year":"1973","unstructured":"Anderberg MR (1973) Cluster analysis for applications. Academic Press, New York"},{"key":"1639_CR20","volume-title":"Algorithms for clustering data","author":"AK Jain","year":"1988","unstructured":"Jain AK, Dubes RC (1988) Algorithms for clustering data. Prentice-Hall, New Jersey"},{"issue":"1","key":"1639_CR21","first-page":"1","volume":"3","author":"T Calinski","year":"1974","unstructured":"Calinski T, Harabasz JA (1974) Dendrite method for cluster analysis. Commun Stat 3(1):1\u201327","journal-title":"Commun Stat"},{"issue":"10","key":"1639_CR22","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1177\/0333102420920644","volume":"40","author":"BL Reidy","year":"2020","unstructured":"Reidy BL, Riddle EJ, Powers SW, Slater SK, Kacperski J, Kabbouche MA et al (2020) Clinic-based characterization of continuous headache in children and adolescents: comparing youth with chronic migraine to those with new daily persistent headache. Cephalalgia 40(10):1063\u20131069. https:\/\/doi.org\/10.1177\/0333102420920644","journal-title":"Cephalalgia"},{"issue":"1","key":"1639_CR23","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s10194-020-01122-5","volume":"21","author":"A Labastida-Ramirez","year":"2020","unstructured":"Labastida-Ramirez A, Benemei S, Albanese M, D\u2019Amico A, Grillo G, Grosu O et al (2020) Persistent post-traumatic headache: a migrainous loop or not? The clinical evidence. J Headache Pain 21(1):55. https:\/\/doi.org\/10.1186\/s10194-020-01122-5","journal-title":"J Headache Pain"},{"issue":"6","key":"1639_CR24","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1177\/0333102420909865","volume":"40","author":"H Ashina","year":"2020","unstructured":"Ashina H, Iljazi A, Al-Khazali HM, Ashina S, Jensen RH, Amin FM et al (2020) Persistent post-traumatic headache attributed to mild traumatic brain injury: deep phenotyping and treatment patterns. Cephalalgia 40(6):554\u2013564. https:\/\/doi.org\/10.1177\/0333102420909865","journal-title":"Cephalalgia"},{"issue":"1","key":"1639_CR25","doi-asserted-by":"publisher","first-page":"333102422113133","DOI":"10.1177\/03331024221131331","volume":"43","author":"C Patterson Gentile","year":"2023","unstructured":"Patterson Gentile C, Aguirre GK, Hershey AD, Szperka CL (2023) Comparison of continuous headache features in youth with migraine, new daily persistent headache, and persistent post-traumatic headache. Cephalalgia 43(1):3331024221131331. https:\/\/doi.org\/10.1177\/03331024221131331","journal-title":"Cephalalgia"},{"issue":"7","key":"1639_CR26","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1111\/head.14362","volume":"62","author":"K Nagaraj","year":"2022","unstructured":"Nagaraj K, Wei DY, Puledda F, Weng HY, Waheed S, Vandenbussche N et al (2022) Comparison and predictors of chronic migraine vs. new daily persistent headache presenting with a chronic migraine phenotype. Headache 62(7):828\u201338. https:\/\/doi.org\/10.1111\/head.14362","journal-title":"Headache"},{"issue":"1","key":"1639_CR27","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1002\/ajmg.c.31426","volume":"169C","author":"M Castori","year":"2015","unstructured":"Castori M, Morlino S, Ghibellini G, Celletti C, Camerota F, Grammatico P (2015) Connective tissue, Ehlers-Danlos syndrome(s), and head and cervical pain. Am J Med Genet C Semin Med Genet 169C(1):84\u201396. https:\/\/doi.org\/10.1002\/ajmg.c.31426","journal-title":"Am J Med Genet C Semin Med Genet"},{"issue":"10","key":"1639_CR28","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1111\/j.1468-2982.2006.01187.x","volume":"26","author":"TD Rozen","year":"2006","unstructured":"Rozen TD, Roth JM, Denenberg N (2006) Cervical spine joint hypermobility: a possible predisposing factor for new daily persistent headache. Cephalalgia 26(10):1182\u20131185. https:\/\/doi.org\/10.1111\/j.1468-2982.2006.01187.x","journal-title":"Cephalalgia"},{"issue":"3","key":"1639_CR29","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1177\/0333102410381145","volume":"31","author":"AM Blumenfeld","year":"2011","unstructured":"Blumenfeld AM, Varon SF, Wilcox TK, Buse DC, Kawata AK, Manack A et al (2011) Disability, HRQoL and resource use among chronic and episodic migraineurs: results from the international burden of migraine study (IBMS). Cephalalgia 31(3):301\u2013315. https:\/\/doi.org\/10.1177\/0333102410381145","journal-title":"Cephalalgia"},{"issue":"15","key":"1639_CR30","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1212\/WNL.0b013e318232ab65","volume":"77","author":"RB Lipton","year":"2011","unstructured":"Lipton RB, Varon SF, Grosberg B, McAllister PJ, Freitag F, Aurora SK et al (2011) OnabotulinumtoxinA improves quality of life and reduces impact of chronic migraine. Neurology 77(15):1465\u20131472. https:\/\/doi.org\/10.1212\/WNL.0b013e318232ab65","journal-title":"Neurology"},{"issue":"1","key":"1639_CR31","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s10072-021-05236-9","volume":"43","author":"R Uniyal","year":"2022","unstructured":"Uniyal R, Chhirolya R, Tripathi A, Mishra P, Paliwal VK (2022) Is new daily persistent headache a fallout of somatization? An observational study Neurol Sci 43(1):541\u2013547. https:\/\/doi.org\/10.1007\/s10072-021-05236-9","journal-title":"An observational study Neurol Sci"},{"issue":"20","key":"1639_CR32","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1212\/WNL.0b013e3182377dbb","volume":"77","author":"AJ Nagy","year":"2011","unstructured":"Nagy AJ, Gandhi S, Bhola R, Goadsby PJ (2011) Intravenous dihydroergotamine for inpatient management of refractory primary headaches. Neurology 77(20):1827\u20131832. https:\/\/doi.org\/10.1212\/WNL.0b013e3182377dbb","journal-title":"Neurology"},{"issue":"6","key":"1639_CR33","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1111\/ner.13282","volume":"24","author":"S Lagrata","year":"2021","unstructured":"Lagrata S, Cheema S, Watkins L, Matharu M (2021) Long-Term outcomes of occipital nerve stimulation for new daily persistent headache with migrainous features. Neuromodulation 24(6):1093\u20131099. https:\/\/doi.org\/10.1111\/ner.13282","journal-title":"Neuromodulation"},{"issue":"1","key":"1639_CR34","doi-asserted-by":"publisher","first-page":"3846","DOI":"10.1038\/s41598-021-83508-2","volume":"11","author":"C Sanchez-Rodriguez","year":"2021","unstructured":"Sanchez-Rodriguez C, Sierra A, Planchuelo-Gomez A, Martinez-Pias E, Guerrero AL, Garcia-Azorin D (2021) Real world effectiveness and tolerability of candesartan in the treatment of migraine: a retrospective cohort study. Sci Rep 11(1):3846. https:\/\/doi.org\/10.1038\/s41598-021-83508-2","journal-title":"Sci Rep"},{"issue":"1","key":"1639_CR35","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s10194-022-01456-2","volume":"23","author":"M Lowe","year":"2022","unstructured":"Lowe M, Murray L, Tyagi A, Gorrie G, Miller S, Dani K et al (2022) Efficacy of erenumab and factors predicting response after 3 months in treatment resistant chronic migraine: a clinical service evaluation. J Headache Pain 23(1):86. https:\/\/doi.org\/10.1186\/s10194-022-01456-2","journal-title":"J Headache Pain"},{"issue":"11","key":"1639_CR36","doi-asserted-by":"publisher","first-page":"3243","DOI":"10.1007\/s00415-020-09989-9","volume":"267","author":"R Messina","year":"2020","unstructured":"Messina R, Lastarria Perez CP, Filippi M, Goadsby PJ (2020) Candesartan in migraine prevention: results from a retrospective real-world study. J Neurol 267(11):3243\u20133247. https:\/\/doi.org\/10.1007\/s00415-020-09989-9","journal-title":"J Neurol"},{"key":"1639_CR37","unstructured":"National Institute for Health and Care Excellence (2009) Depression in adults: recognition and management (Clinical guideline [CG90]). https:\/\/www.nice.org.uk\/guidance\/CG90. Accessed 25 Jan 2021"},{"issue":"1","key":"1639_CR38","doi-asserted-by":"publisher","first-page":"2804","DOI":"10.1038\/s41598-020-59738-1","volume":"10","author":"YW Woldeamanuel","year":"2020","unstructured":"Woldeamanuel YW, Sanjanwala BM, Peretz AM, Cowan RP (2020) Exploring natural clusters of chronic migraine phenotypes: a cross-sectional clinical study. Sci Rep 10(1):2804. https:\/\/doi.org\/10.1038\/s41598-020-59738-1","journal-title":"Sci Rep"}],"container-title":["The Journal of Headache and Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-023-01639-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10194-023-01639-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-023-01639-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T06:02:52Z","timestamp":1700460172000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejournalofheadacheandpain.biomedcentral.com\/articles\/10.1186\/s10194-023-01639-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,16]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1639"],"URL":"https:\/\/doi.org\/10.1186\/s10194-023-01639-5","relation":{},"ISSN":["1129-2377"],"issn-type":[{"value":"1129-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,16]]},"assertion":[{"value":"5 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"S. Cheema is supported by a research fellowship sponsored by Abbott.A. Stubberud has received speaker honoraria from TEVA.K. Rantell reports no disclosures relevant to the manuscript.P. Nachev reports no disclosures relevant to the manuscript.E. Tronvik reports no disclosures relevant to the manuscript.M. Matharu is chair of the medical advisory board of the CSF Leak Association; has served on advisory boards for Allergan, Autonomic Technologies Inc, Eli Lilly, Novartis, Pfizer, Salvia and TEVA; has received payment for educational presentations from Allergan, electroCore, Eli Lilly, Novartis and TEVA; has received grants from Abbott, Medtronic and electroCore; and has a patent on system and method for diagnosing and treating headaches (WO2018051103A1, issued).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"109"}}